Business Description
Sera Prognostics Inc
NAICS : 621512
SIC : 8734
2749 East Parleys Way, Suite 200, Salt Lake City, UT, USA, 84109
Description
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 66.7 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.57 | |||||
Beneish M-Score | 2.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.62 | |||||
9-Day RSI | 65.6 | |||||
14-Day RSI | 64.68 | |||||
6-1 Month Momentum % | -74 | |||||
12-1 Month Momentum % | -84.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.8 | |||||
Quick Ratio | 14.8 | |||||
Cash Ratio | 14.64 | |||||
Days Sales Outstanding | 83.18 | |||||
Days Payable | 3811.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.39 | |||||
Operating Margin % | -27900 | |||||
Net Margin % | -27921.82 | |||||
ROE % | -58.04 | |||||
ROA % | -35.13 | |||||
ROIC % | -169.95 | |||||
ROC (Joel Greenblatt) % | -2434.5 | |||||
ROCE % | -36.41 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 433.33 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.69 | |||||
EV-to-EBIT | 0.54 | |||||
EV-to-EBITDA | 0.55 | |||||
EV-to-Revenue | -149.72 | |||||
EV-to-Forward-Revenue | 6.31 | |||||
EV-to-FCF | 0.64 | |||||
Price-to-Net-Current-Asset-Value | 0.81 | |||||
Price-to-Net-Cash | 0.82 | |||||
Earnings Yield (Greenblatt) % | 185.19 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:SERA
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.165 | ||
EPS (TTM) ($) | -1.57 | ||
Beta | 0 | ||
Volatility % | 85.76 | ||
14-Day RSI | 64.68 | ||
14-Day ATR ($) | 0.217366 | ||
20-Day SMA ($) | 2.27 | ||
12-1 Month Momentum % | -84.44 | ||
52-Week Range ($) | 1.15 - 11.9 | ||
Shares Outstanding (Mil) | 31 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sera Prognostics Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |